Treatment of binge-eating disorder with topiramate: A clinical case series

Journal of Clinical Psychiatry

Volumn 61, Issue 5, 2000, Pages 368-372

  Shapira, Nathan Andrew ^a   Goldsmith, Toby D ^a   McElroy, Susan L ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBAMAZEPINE; CLONAZEPAM; CLOZAPINE; FLUOXETINE; GABAPENTIN; GLIPIZIDE; LAMOTRIGINE; LIOTHYRONINE SODIUM; LORAZEPAM; METFORMIN; METHYLPHENIDATE; PAROXETINE; PHENYTOIN; PROPRANOLOL; QUETIAPINE; TOPIRAMATE; TRANYLCYPROMINE; TRAZODONE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; ARTICLE; BINGE EATING DISORDER; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; NEUROLOGIC DISEASE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 0034078231     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0508     Document Type: Article

References (16)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
2. de Zwaan M, Mitchell JE, Raymond NC, et al. Binge eating disorder: clinical features and treatment of a new diagnosis. Harv Rev Psychiatry 1994;1:310-325
3. Spitzer RL, Devlin M, Walsh BT, et al. Binge eating disorder: a multisite field trial of the diagnostic criteria. Int J Eat Disord 1992;11:191-203
4. Spitzer RL, Yanovski S, Wadden T, et al. Binge eating disorder: its further validation in a multisite study. Int J Eat Disord 1993;13:137-153
5. Privitera MD. Topiramate: a new antiepileptic drug. Ann Pharmacother 1997;31:1164-1173
6. Calabrese JR, Shelton MD III, Keck PE Jr, et al. Topiramate in severe treatment-refractory mania. In: New Research Program and Abstracts of the 151st Annual Meeting of the American Psychiatric Association; June 2, 1998; Toronto, Canada. Abstract NR202:121-122
7. Marcotte D. Use of topiramate, a new anti-epileptic as a mood stabilizer. J Affect Disord 1998;50:245-251
8. Stanley BG, Ha LH, Spears LC, et al. Lateral hypothalamic injections of glutamate, kainic acid, D,L-alpha-amino-3-hydroxy-5-methyl-isoxazole propionic acid or N-methyl-D-aspartic acid rapidly elicit intense transient eating in rats. Brain Res 1993;613:88-95
9. Stanley BG, Willett VL III, Donias HW, et al. The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating. Brain Res 1993;630:41-49
10. Green RS, Rau JH. Treatment of compulsive eating disturbances with anti-convulsant medication. Am J Psychiatry 1974;131:428-432
11. Hudson JI, Pope HG. The role of anticonvulsants in the treatment of bulimia. In: McElroy SL, Pope HG, eds. Use of Anticonvulsants in Psychiatry: Recent Advances. Clifton, NJ: Oxford Health Care; 1988:141-154
12. Hudson JI, McElroy SL, Raymond NC, et al. Fluvoxamine in the treatment of binge eating disorder: a multicenter placebo-controlled, doubleblind trial. Am J Psychiatry 1998;155:1756-1762
13. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1996;152: 1130-1138
14. Benazzi F. Antidepressant-associated hypomania in outpatient depression: a 203 case study in private practice. J Affect Disord 1997;46:73-77
15. Kruger S, Shugar G, Cooke RG. Comorbidity of binge eating disorder and the partial binge eating syndrome with bipolar syndrome. Int J Eat Disord 1996;19:45-52
16. Stunkard AJ. Eating pattern and obesity. Psychiatr Q 1959;33:284-292